Upgrade to SI Premium - Free Trial

Piper Jaffray On Gilead (GILD) - It Stinks But If You Hold Your Nose It's Not That Bad

February 8, 2017 6:12 AM
Piper Jaffray lowered its price target on Gilead Sciences (NASDAQ: GILD) to $95.00 (from $102.00) while maintaining a Overweight rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments

Next Articles